Cities Changing Diabetes


Overview


According to the International Diabetes Federation, 415 million people across the world have diabetes, two-thirds of whom are living in urban areas. Canada is no exception with approximately 3.5 million people living with diabetes, a number expected to rise to 5 million by 2025. Cities Changing Diabetes (CCD) is a partnership programme initiated by Novo Nordisk in 2014 to address the dramatic rise of urban diabetes. It has been developed in partnership with University College London and Steno Diabetes Center, as well as a range of local partners including the diabetes/health community, city governments, academic institutions, city experts from a variety of fields and civil society organisations.

The purpose of the CCD Programme is to identify and address the root cause of urban diabetes in major cities around the world. Cities Changing Diabetes now has 100+ partners in 16 cities across the world: Copenhagen, Houston, Vancouver, Johannesburg, Mexico City, Rome, Shanghai, Tianjin, Xiamen, Leicester, Mérida, Buenos Aires, Hangzhou, Beirut, Koriyama and Beijing. Vancouver joined in November 2016 with Dr. Scott Lear as the local academic lead and a growing list of partners including the City of Vancouver, Vancouver Coastal Health, Diabetes Canada and Radius SFU. A number of exciting projects are taking place among the Vancouver partners. We have listed the projects Dr. Lear is leading below. More information on what else is going on locally can be found on the CCD Vancouver webpage; information on the other cities can be found here.


Associated Projects


Vancouver Diabetes Priorities Assessment (VDPA) Study

Qualitative vulnerability assessment of Greater Vancouverites living with type 2 diabetes.

North American Healthy Cities Research Hub

Knowledge sharing and exchange collaboration between the first three North American CCD Cities – Houston, Mexico City, and Vancouver.